Picture of Disruptive Pharma AB (publ) logo

DPHA — Disruptive Pharma AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Guard Therapeutics RMC-035 Development Plan Receives Positive Feedback From FDA

Jan 15 (Reuters) - Guard Therapeutics International AB (publ)  GUARD.ST :
    * FDA PROVIDES POSITIVE FEEDBACK TO GUARD THERAPEUTICS REGARDING THE CONTINUED DEVELOPMENT
PLAN
FOR RMC-035

Source text for Eikon:  ID:nMFN2Gh0tl 
Further company coverage:  GUARD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Disruptive Pharma AB (publ)

See all news